1. Discovery of cyclic guanidine-linked sulfonamides as inhibitors of LMTK3 kinase
   Maria A. Ortiz et al, 2020, Bioorganic & Medicinal Chemistry Letters CrossRef
2. The structure-function relationship of oncogenic LMTK3
   Angeliki Ditsiou et al, 2020, Science Advances CrossRef
3. Knockdown of LMTK3 in the Endometrioid Adenocarcinoma Cell Line Ishikawa: Inhibition of Growth and Estrogen Receptor α
   Guiyang Cai et al, 2021, Frontiers in Oncology CrossRef
4. Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway
   Cheng Wang et al, 2021, Bioengineered CrossRef
5. Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer
   Ghassan M. Saed et al, 2024, Molecular Therapy: Oncology CrossRef
6. Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
   Aradhana Rani et al, 2019, Frontiers in Endocrinology CrossRef
7. LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
   Tao Jiang et al, 2020, FEBS Open Bio CrossRef
8. The multifaceted role of lemur tyrosine kinase 3 in health and disease
   Angeliki Ditsiou et al, 2021, Open Biology CrossRef
9. The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor
   Alessandro Agnarelli et al, 2023, International Journal of Molecular Sciences CrossRef
10. Therapeutic Efficacy of Quercetin and Its Nanoformulation Both the Mono‐ or Combination Therapies in the Management of Cancer: An Update with Molecular Mechanisms
    Tanzila Akter Eity et al, 2024, Journal of Tropical Medicine CrossRef